Eptifibatide Pharmaserve is a peptide-based antagonist for glycoprotein IIb/IIIa used in the medical

Suzhou Pharmaserve Technology Co., Ltd., established in 2019 in Suzhou Industrial Park, is a trading company specializing in peptide-based active pharmaceutical ingredients, including Semaglutide, Liraglutide, Tirzepatide, Octreotide Acetate, Cetrorelix Acetate, Ganirelix Acetate, Desmopressin, Oxytocin, Carbetocin, and Atosiban Acetate, alongside natural extracts, finished dosage forms, API equipment, and food additives. Operating in compliance with GMP principles and exporting essentially 100% of its output, the company supplies distributors, wholesalers, and pharmaceutical companies across more than 20 countries including the US, Mexico, Brazil, Turkey, and Middle Eastern markets, supported by a manufacturing facility with over 100 staff and a CDMO service offering. It emphasizes its global B2B reach, certification and regulatory compliance, and reliable, prompt logistics as key strengths, though it notes it does not yet hold patents of its own.